EnClear Therapies’ system designed to treat amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases was one of five first-place winners of the Massachusetts Life Sciences Center (M2D2) $200K Challenge. Cambridge, Mass.-based EnClear Therapies’ device-based system was designed to halt the progression of neurodegenerative diseases by removing toxic proteins that build up in the brain and […]
University of Massachusetts
Researchers from the University of Massachusetts Amherst have designed a nanoparticle delivery system to assist the gene-editing tool known as CRISPR/Cas9 across the cell membrane and into the cell nucleus, effectively avoiding the cell’s natural defense mechanisms. The team’s work was published in ACS Nano. “CRISPR has two components: a scissor-like protein called Cas9, and an […]
Researchers at the University of Massachusetts Medical School have developed photodynamic nanoparticles that can effectively target deep-tissue tumors. The team’s work was published in the Journal of the American Chemical Society. “This study signals a major step forward in photodynamic therapy by developing a new class of NIR-absorbing biodegradable organic nanoparticles for a highly effective […]
Researchers from the University of Massachusetts-Amherst have developed polymer-stabilized droplet carriers that can identify and engulf nanoparticles to bring them into a cell. The team was inspired by proteins that can recognize microbes or debris and then encapsulate the material to get rid of it. The team believes that this demonstration of surface-to-surface nanoparticle transport, […]
MASSDEVICE ON CALL — During the June 5 debate for the Mass. Senate seat, Rep. Ed Markey (D) promised to introduce an amendment to the Affordable Care Act to reduce the medical device tax.
Markey said he would make up the losses with decreased tax breaks to oil companies. While he affirmed his support for healthcare reform during the debate, he reminded voters that he opposes the device tax.
Lumbar spine surgery company TranS1 Inc. (NSDQ:TSON) priced a public offering of 6.2 million shares of common stock at $3.25 per share, expecting to raise up to $20.2 million.
TranS1 plans to use the funds for additional clinical trials, reimbursement efforts, sales personnel, research and product development activities and working capital, according to SEC filings. It added that funds may go toward acquisition of or investment in technologies, products or assets that complement the business.
UMass Amherst Nanotechnology Center Receives $20 Million Renewal of Federal Grant to Boost Advanced Manufacturing, Economic Growth
AMHERST, Mass. – The University of Massachusetts Amherst has received a five-year, $20 million grant from the National Science Foundation (NSF) to support a national research center on nanomanufacturing. The grant will fund the university’s Center for Hierarchical Manufacturing (CHM).
Wireless devices have changed the way health information moves, making data more abundant and more accessible. But it’s also made medical devices more vulnerable.
Researchers at MIT and the University of Mass. Amherst are the first to develop a technology that could protect the millions of existing medical device implants without altering or replacing them.
Wireless technologies made their mark on medical devices in a big way, attaching themselves to everything from pacemakers and defibrillators to insulin pumps and nerve stimulators.
The University of Massachusetts made eight grants totaling $200,000 to fund medical device research by faculty members.
The awards, which are given annually, are funded by the university’s Commercial Ventures and Intellectual Property (CVIP) Technology Development Fund.
Awardees included faculty from the UMass Amherst, Worcester and Lowell campus.
The projects that received funding include a biodegradable bandage system and disposable mini pressure sensors to aid cardiac surgery.